A newly configured federal vaccine panel's June 25 action is expected to improve options to protect infants from potentially ...

Respiratory syncytial virus is common but it can be dangerous for some infants and young kids. Here's everything parents need ...

A CDC advisory panel on Thursday voted 5-2 to recommend the use of a new preventative RSV therapy in babies, Merck’s ...

The risk for severe RSV-related outcomes was effectively reduced among children and infants who received nirsevimab in real-world clinical settings.

The eight new ACIP members met for the first time June 25 after Kennedy fired all 17 original members of the committee June 9 ...

Citing Indian Council for Medical Research (ICMR) and published studies, Dr Bhavesh Kotak, Head of Medical Affairs at Dr ...

Hospital readmission risk in pediatric patients was higher in those who were first admitted for RSV than in those who were first admitted for influenza or hMPV.

Discover how Professor Shabir Madhi is advancing maternal vaccines to safeguard newborns from RSV, GBS, and more.

The CDC's newly reconstituted Advisory Committee on Immunization Practices (ACIP) voted 5-2 in support of infants younger than 8 months receiving clesrovimab (Enflonsia) to prevent respiratory ...

An outside group of experts agreed that the CDC should recommend a new antibody drug that offers protection against RSV for ...

A major UK-led clinical trial has found that a treatment commonly used to help premature babies breathe offers no benefit for ...

The vote offers a sigh of relief to doctors and public health experts worried about vaccine skepticism creeping into policymaking.